Cargando…
Cardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis
BACKGROUND: Trimetazidine is an anti-ischemic agent with anti-oxidant activity. This study sought to evaluate the impact of oral trimetazidine on extent of myocardial damage in diabetic patients who were presented with anterior wall ST-segment elevation myocardial infarction (STEMI). METHODS: One hu...
Autor principal: | Shehata, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358175/ https://www.ncbi.nlm.nih.gov/pubmed/28392876 http://dx.doi.org/10.14740/cr330w |
Ejemplares similares
-
The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020) -
Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013) -
Thrombolysis in Myocardial Infarction (TIMI) Risk Score Assessment for Complications in Acute Anterior Wall ST Elevation Myocardial Infarction
por: Khan, Rozi, et al.
Publicado: (2020) -
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
por: Miki, Takayuki, et al.
Publicado: (2012) -
Beneficial effects of trimetazidine on expression of serotonin and serotonin transporter in rats with myocardial infarction and depression
por: Liu, Meiyan, et al.
Publicado: (2018)